Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its key gene therapy treatment appeared at risk. The Food and Drug Administration will request that the company ...

The Center of Disease Control (CDC) and the U.S. Food and Drug Administration (FDA) are investigating a multistate outbreak ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute ...

The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...

The U.S. Food and Drug Administration will request Sarepta Therapeutics to voluntarily stop all shipments of its gene therapy ...

With no clear rules from health or drug authorities, thousands of businesses openly sell psilocybin mushrooms even though the ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have led to some women avoiding the option, even if it could help them.

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...

Smith Hunter C, Chief Financial Officer of Rhythm Pharmaceuticals( RYTM 0.25%), reported mixed transactions totaling 42,120 ...